Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hong

Showing results (211-220 of 273) with videos related to

Pageof 28
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2015
First-in-Human Phase I Study of GSK2126458, an Oral Pan-Class I Phosphatidylinositol-3-Kinase Inhibitor, in Patients with Advanced Solid Tumor MalignanciesPamela Munster, Rahul Aggarwal, David Hong, et al.
Oncotarget|November 21, 2017
Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experienceJennifer B Goldstein, Chad Tang, Kenneth R Hess, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 21, 2020
Optimal Timing of Venoarterial-Extracorporeal Membrane Oxygenation in Acute Myocardial Infarction Patients Suffering From Refractory Cardiogenic ShockKi Hong Choi, Jeong Hoon Yang, David Hong, et al.
Scientific Reports|July 6, 2019
Prognostic implications of post-percutaneous coronary intervention neutrophil-to-lymphocyte ratio on infarct size and clinical outcomes in patients with acute myocardial infarctionDavid Hong, Ki Hong Choi, Young Bin Song, et al.
The Korean Journal of Internal Medicine|February 29, 2024
Current evidence for prognostic benefit of intravascular imaging-guided percutaneous coronary intervention in chronic total occlusion interventionDavid Hong, Sung Eun Kim, Seung Hun Lee, et al.
Revista Espanola De Cardiologia (English Ed.)|November 14, 2024
Safety and efficacy of antiplatelet therapy in patients with intermediate coronary artery stenosis and deferred revascularizationDavid Hong, Seung Hun Lee, Jihye Heo, et al.
NPJ Precision Oncology|July 31, 2024
Phase II study of talazoparib in advanced cancers with BRCA1/2, DNA repair, and PTEN alterationsSarina A Piha-Paul, Chieh Tseng, Cheuk Hong Leung, et al.
JCO Precision Oncology|July 12, 2021
Comprehensive Clinical and Molecular Characterization of <i>KRAS</i> <sup>G12C</sup>-Mutant Colorectal CancerJason T Henry, Oluwadara Coker, Saikat Chowdhury, et al.
Annals of Intensive Care|June 18, 2020
Multidisciplinary team approach in acute myocardial infarction patients undergoing veno-arterial extracorporeal membrane oxygenationDavid Hong, Ki Hong Choi, Yang Hyun Cho, et al.
Cancer|September 24, 2004
2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinomaStephen G Swisher, Jeremy Erasmus, Mary Maish, et al.
Pageof 28

Showing results (211-220 of 273) with videos related to

Sort By:
Pageof 28
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2015
First-in-Human Phase I Study of GSK2126458, an Oral Pan-Class I Phosphatidylinositol-3-Kinase Inhibitor, in Patients with Advanced Solid Tumor MalignanciesPamela Munster, Rahul Aggarwal, David Hong, et al.
Oncotarget|November 21, 2017
Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experienceJennifer B Goldstein, Chad Tang, Kenneth R Hess, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 21, 2020
Optimal Timing of Venoarterial-Extracorporeal Membrane Oxygenation in Acute Myocardial Infarction Patients Suffering From Refractory Cardiogenic ShockKi Hong Choi, Jeong Hoon Yang, David Hong, et al.
Scientific Reports|July 6, 2019
Prognostic implications of post-percutaneous coronary intervention neutrophil-to-lymphocyte ratio on infarct size and clinical outcomes in patients with acute myocardial infarctionDavid Hong, Ki Hong Choi, Young Bin Song, et al.
The Korean Journal of Internal Medicine|February 29, 2024
Current evidence for prognostic benefit of intravascular imaging-guided percutaneous coronary intervention in chronic total occlusion interventionDavid Hong, Sung Eun Kim, Seung Hun Lee, et al.
Revista Espanola De Cardiologia (English Ed.)|November 14, 2024
Safety and efficacy of antiplatelet therapy in patients with intermediate coronary artery stenosis and deferred revascularizationDavid Hong, Seung Hun Lee, Jihye Heo, et al.
NPJ Precision Oncology|July 31, 2024
Phase II study of talazoparib in advanced cancers with BRCA1/2, DNA repair, and PTEN alterationsSarina A Piha-Paul, Chieh Tseng, Cheuk Hong Leung, et al.
JCO Precision Oncology|July 12, 2021
Comprehensive Clinical and Molecular Characterization of <i>KRAS</i> <sup>G12C</sup>-Mutant Colorectal CancerJason T Henry, Oluwadara Coker, Saikat Chowdhury, et al.
Annals of Intensive Care|June 18, 2020
Multidisciplinary team approach in acute myocardial infarction patients undergoing veno-arterial extracorporeal membrane oxygenationDavid Hong, Ki Hong Choi, Yang Hyun Cho, et al.
Cancer|September 24, 2004
2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinomaStephen G Swisher, Jeremy Erasmus, Mary Maish, et al.
Pageof 28